Coverage is the real problem, not detection. The teams that will thrive over the next five years are the ones rebuilding ...

For children with suspected rare diseases, access to timely genomic testing remains uneven and, too often, out of reach. Too ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...